-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.INR↓
Mitarbeiter
19.789
Zahlte zuletzt am 03.08.2020 eine Dividende von 6 . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von
Dir gefallen die Informationen zu Lupin Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Lupin Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Lupin Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Lupin Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
37 News & Informationen zur Lupin Limited Aktie
Dalal Street Week Ahead | 10 key factors that will keep traders busy next week
As per Ajit Mishra of Religare Broking, the broader market may underperform in near future. Investors should focus on index majors and other heavyweights and maintain extra caution while selecting stocks from the mid and small-cap space.
Earnings, macro data, global trends to dictate markets this week: Analysts
Read more about Earnings, macro data, global trends to dictate markets this week: Analysts on Business Standard. Markets this week would be guided by the ongoing quarterly earnings, macroeconomic data announcements and global trends, analysts said.The government will release industrial production data for June and inflation data for July this week.The RBI
Nifty scales 16K mark for first time, Sensex hits record high: Key factors that fuelled the rally
Nifty scaled the key 16,000 mark today as across the board buying despite subdues global cues lifted market sentiment. The 50-stock index zoomed 140 points to a record high of 16,025, signaling the underlying bullish sentiment despite rising coronavirus cases and fears of high inflation.
Market ends lower for 2nd straight week; smallcaps outperform
Here are the key highlights from the week gone by.
Lupin acquires Melbourne-based drug maker SCP to bolster Australia generics business
As a part of the transaction, Lupin will gain access to over 60 registered products having sales of over AUD 30 million
Stock market update: Nifty Pharma index falls 0.32%
The Nifty Pharma index closed 0.32 per cent down at 13920.35.
Nifty Pharma tanks 4.33%, records worst intra-day fall since December; Dr Reddy’s plummets 10%
Nifty Pharma index came under attack from bears on Tuesday forcing the sectoral gauge to close 4.33% lower, the worst single-day fall recorded by the index since December last year.
Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months
Read more about Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months on Business Standard. Alembic Pharma and Dr Reddy's Labs plunged 12% and 11%, respectively in intra-day trade post their June quarter results
Stock market update: Nifty Pharma index advances 0.15%
The Nifty Pharma index closed 0.15 per cent up at 14597.85.
Glenmark Life Sciences IPO opens on July 27: 10 things to know before the issue
Glenmark Life Sciences IPO: The company plans to raise Rs 1,497.85 crore at the lower end and Rs 1,513.6 crore at the higher end of the price band.
Nicox Provides Second Quarter 2021 Business and Financial Highlights and Strategic Update
Press ReleaseNicox Provides Second Quarter 2021 Business and Financial Highlights and Strategic Update Lead value drivers are 100% ownership of NCX 470…
Hot Stocks | Can bet on Lupin, Tata Steel and IndusInd Bank for short term
If Nifty breaks the 15,920 level, then it may witness a major breakout which will help them cross the 16,100 level, said Rohan Patil of Bonanza Portfolio
Global Dry Eye Medication Market Report 2021: Historic Analysis and Forecasts, 2015-2020, 2020-2025F, 2030F
DUBLIN, July 14, 2021 /PRNewswire/ — The 'Dry Eye Medication Global Market Report 2021: COVID-19 Impact and Recovery to 2030' report has been add…
Sensex Down 110 Points; Nifty Dips Below 15,800
(RTTNews) – Indian shares opened lower on Wednesday, tracking weakness in global markets after the latest U.S. inflation report came in well above…
Buy HDFC, Axis Bank, Lupin, M&M stocks to pocket gains; Nifty support at 15,700-15,750
On Wednesday 15900/15930 (53000/53100) would be major hurdles and support would be at 15730/52500 and 15700/52400 levels.
Ahead of Market: 10 things that will decide stock action on Wednesday
Independent analyst Manish Shah said the 15,900-15,950 zone has been tested three times. “The general rule is that the price should go through the fourth time. Odds of an upside breakout are higher,” he said.
Gainers & Losers: 10 stocks that moved most on July 13
Among the sectors, barring IT, teck and FMCG, all ended in the green, with banking and financial indices rising over a percent each.
Lupin Gains On Receiving US FDA Nod To Launch Drug For Onychomycosis
Lupin received approval to launch Tavaborole Topical Solution, 5 per cent in United States (US) from the United States Food and Drug Administration (FDA).
Lupin Q1 PAT seen up 474% YoY to Rs 613.6 cr: ICICI Direct
Net Sales are expected to increase by 20.6 percent Y-o-Y (up 12.5 percent Q-o-Q) to Rs 4,256 crore, according to ICICI Direct.
Nifty stuck in a range; 10 trading ideas that could give 6-18% return
For the index to move higher now, a close above 16,000 is required, say experts. Though multiple attempts to breach the 16,000-mark have failed, what bodes well for the market is that there has not been any brutal correction so far, they say.
Rising oil prices, strong dollar keep traders on the edge: Sacchitanand Uttekar of Tradebulls Securities
If we look at the key oscillators, and trend strength indicators, they are yet to quote above the overbought thresholds which make the dips lucrative for buying, says Uttekar.
3 Top Rated And Best Contra Equity Funds To Invest In India 2021 For Exceptional Gains
As the term suggest Contra fund these tend to park funds against the market sentiment or work with the contrarian view, this is with respect to both the securities that the fund buys or sell and even with respect to the strategy it adopts. The assumption on which these funds work is that too much of concentration tends to make the market either very expensive or cheap at times.
Happy birthday, Big Bull! Here's why he inspires investors all the time
Jhunjhunwala, who started off his investing journey with a measly capital of Rs 5,000, also marks his 36th year on Dalal Street this year.
Enroute To Recovery: CFOs On Changes Here To Stay
CFOs explain how leadership in the new norm is also about showing your vulnerability, seeking help and not acting as heroes, , cfos, CFOs roundtable
Lupin Arm Gets Supplemental New Drug Application Approval From USFDA For Solosec
Shares of Lupin Ltd closed at Rs 1,146.25 per scrip on BSE, down 0.26 per cent from its previous close., , sNDA, usfda, Drug firm, lupin, shares
Nifty Ends Above 15,700; Small-cap, Mid-cap Outperform
In a volatile session, benchmark indices snapped a four-day losing trend and closed higher. The S&P BSE Sensex closed the day at 52484.67 points, while the Nifty50 index closed above 15,700 points. The Nifty Bank, Private Bank, PSU Bank, Media, and Financial Services indexes all gained 0.4-0.63 percent.
Stocks To Watch; TCS, Lupin, Coal India
TCS has partnered with John Wiley & Sons, an American multinational publishing company, to modernise its e-commerce platform with SAP Commerce
Lupin arm gets supplemental new drug application approval from US regulator for Solosec
The drug was approved in the US in 2017 for the treatment of bacterial vaginosis in adult women, the company said.
Lupin gets USFDA nod for HIV drug under PEPFAR
Lupin got a green signal from the US health regulator to sell HIV drug in the American market. The product that has received a nod under US President's Emergency Plan for AIDS Relief (PEPFAR).
USFDA warning letter on Lupin's Somerset facility cites repeated GMP violations at Lupin's manufacturing network
Bajaj Healthcare requests Indian patent office to grant compulsory licence for COVID-19 drug
The firm approached the Indian Patent Office after Eli Lilly & Company on two occasions declined to sign the voluntary licence for manufacturing and supply of COVID-19 drug Baricitinib
Nifty Opens Higher, Sensex Scales Past 53,000 Points Again
The Sensex and the Nifty opened Monday morning trade higher, even as Asian markets continued to trade mixed, after data showed that Chinese Industrial profits for May slowed.
Buzzing Stocks: Thyrocare, Barbeque Nation, NALCO and other stocks in news today
Stocks In News: Check out the companies making the biggest headlines before the opening bell.
Exclusive web-tracking data suggests Netflix usage continued to climb internationally during Q4, while North American usage dipped
Omar Sy stars in
Global Alzheimer's Disease Diagnostics and Therapeutics Market to 2025: Use of Biomarkers in Diagnosis and Drug Development & Large Number of Drugs in Pipeline
Dublin, Jan. 14, 2021 (GLOBE NEWSWIRE) — The
‘Lupin’: New Netflix Original Series From France With A Charismatic Leading Man
Captivating new French series led by French actor Omar Sy is Netflix's next hit.
Worldwide Industry for Respiratory Inhaler Devices to 2025 – Widespread Rise in Chronic Respiratory Diseases Presents Opportunities
/PRNewswire/ — The “Global Respiratory Inhaler Devices Market (2020-2025) by Product, Technology, End-User, Disease Indication and Geography and the Impact of…